Futura Medical PLC Block Listing Update (4913X)
25 November 2017 - 12:08AM
UK Regulatory
TIDMFUM
RNS Number : 4913X
Futura Medical PLC
24 November 2017
24 November 2017
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology makes the following
update on its block listing, pursuant to AIM Rule 29 and Schedule
Six of the AIM Rules for Companies. All figures relate to options
over ordinary shares of 0.2 pence each.
The table below provides further detail.
Name of company: Futura Medical plc
Name of scheme: Unapproved Share Option Scheme ("USOS")
EMI Share Option Scheme ("EMI")
Period of return: From: 25 May 2017
To: 24 November 2017
Number and class of securities not issued under
the scheme(s) at start of period USOS: 2,446,110
EMI: 3,021,390
Total: 5,467,500
Number of securities issued under the scheme(s) USOS: -
during the period
Number of securities lapsed under the scheme(s)
during the period
EMI: -
USOS: 50,000
EMI: 350,000
Balance under the scheme(s) of securities not
yet issued at the end of the period USOS: 2,396,110
EMI: 2,671,390
Total: 5,067,500
Number and class of securities originally USOS: 814,424 on 25 May 2011, 1,202,280 on 8 October
admitted and the date of admission 2013, 1,466,208 on 25 May 2017
USOS Total: 3,482,912
EMI: 1,520,576 on 25 May 2011, 1,467,720 on 8 October
2013
1,893,792 on 25 May 2017
EMI Total: 4,882,088
Total: 8,365,000
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670
For further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483
685 670
Email to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496
Corporate Finance 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0) 20 7466
/ Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPGGWUGUPMGWC
(END) Dow Jones Newswires
November 24, 2017 08:08 ET (13:08 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024